I
schemic heart disease leads to very high morbidity and mortality despite existing treatment options (1) (2) (3) . Autologous cell transplantation has been developed as a promising new therapy for cardiac repair (4, 5) . Multipotent mesenchymal stromal cells (MSCs) from bone marrow represent a robust and accessible stem cell resource characterized by cells with great capacity for self-renewal and multipotent differentiation (6, 7) . Transplantation of MSCs into the ischemic heart has been shown to stimulate endogenous cardiac stem cell proliferation and tissue regeneration (8, 9) . However, the benefits of cardiac cell therapy are diminished in aged individuals due to the reduced proliferative and self-renewal capacities of aged stem cells and increased cell senescence (10) (11) (12) (13) (14) (15) . Allogeneic stem cells have been shown to have the similar early benefits as autologous cells (16) , but the long term effects of allogeneic cells have not been established and concerns have been expressed that allogeneic cells may be rejected and lose their benefit late after engraftment (17) . Therefore, effective methods to rejuvenate aged human stem cells to improve their regenerative capability are needed to help treat the increasing number of elderly patients with ischemic heart disease and heart failure.
First described in the nervous system (18, 19) , neuron-derived neurotrophic factor (NDNF) has several biological functions that align with the goals of stem cell functional restoration, including the promotion of cell growth and the inhibition of apoptosis (19) . Recently, secretion of NDNF from endothelial cells was found to promote endothelial cell function and survival following ischemic limb injury in mice (20) , and systemically increasing NDNF levels in mice improved cardiac function, increased angiogenesis, and reduced cardiomyocyte apoptosis following myocardial infarction (MI) (21) . Although these studies provide evidence that NDNF can facilitate cardiomyocyte function and cardiac repair after injury, they are limited by the fact that NDNF expression was experimentally increased only in mouse cells. Thus, the extent to which NDNF's proangiogenic and antiapoptotic effects may apply to human cells and specifically to human stem cells remains unknown.
Moreover, the effect of age on the expression level of NDNF in human stem cells and its implications for stem cell rejuvenation have not been explored.
In the current study, we investigated whether increasing the expression of NDNF could rejuvenate aged human bone marrow mesenchymal stromal cells and Y (NDNF protein level) was analyzed using a correlation regression analysis. n ¼ 8 to 13/group. ACTB ¼ beta-actin.
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NDNF Overexpression Rejuvenates Aged hBM-MSCs [regucalcin] protein level) was analyzed using a correlation regression analysis. Abbreviations as in Figure 1 . NDNF-transduced cells, n ¼ 6/group. GAPDH ¼ glyceraldehyde 3-phosphate dehydrogenase; other abbreviations as in Figure 1 .
NDNF Overexpression Rejuvenates Aged hBM-MSCs were captured 28 days after MI in mice ( Figure 5A ).
Fractional shortening was similar among all 6 groups before MI and cell transplantation (day 0) and decreased by a similar degree 7 days following MI.
However, 28 days after MI, fractional shortening was significantly greater in the oldþNDNF group than in the fibroþNDNF and old groups ( Figure 5B ). Representative pressure-volume loop images taken 28 days after MI are depicted in Figure 5C . The end-systolic volume of oldþNDNF mice was significantly smaller than that of the fibroþNDNF and old groups 28 days after MI ( Figure 5D ), while end-diastolic volume was smallest in young mice ( Figure 5E ). Systolic function as measured by dP/dt max ( Figure 5F ) and diastolic function as measured by dP/dt min ( Figure 5G ) was significantly better in the oldþNDNF group than in the fibroþNDNF and old groups 28 days after MI. were also assessed at various time points after MI by echocardiography ( Figures 6C and 6D) . Left ventricular internal end-systolic dimension ( Figure 6C ) was significantly lower in oldþNDNF mice than in NDNFþfibro and old mice 28 days after MI. Both capillary (stained with isolectin) ( Figure 6E ) and arteriole (stained with alpha smooth muscle actin)
( Figure 6F ) densities were significantly higher in the Song et al. 
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Song et al. diastolic function as measured by dP/dt min were significantly better in oldþNDNF mice than in old mice. dP/dt max ¼ maximal rate of pressure increase during isovolumic contraction; dP/dt min ¼ maximal rate of pressure decrease during isovolumic relaxation; other abbreviations as in Figure 1 . Figure 1 .
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CONCLUSIONS
Our findings suggest that NDNF could be a new factor that contributes to the rejuvenation of aged human stem cells and NDNF-rejuvenated stem cells may be a potent vehicle to combine cell and gene therapies to improve cardiac repair of the aged heart after ischemic injury. 
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